Yahoo Finance report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
Why SOPH Stock dropped -4.27% Today — RQD Quant Desk Flash
SOPHiA GENETICS SA (SOPH) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SOPH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, SOPHiA GENETICS SA (NASDAQ: SOPH) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $7.63 (-4.27% 1D, market cap $678.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 714 tracked Technology issuers, SOPH ranks #241 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SOPH compare to DDI and BRUN in the Technology sector?
▼
Within the Technology sector (EDP Services), SOPH carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, DDI (DoubleDown Interactive Co. Ltd. American Depository Shares) holds a C- grade (61/100 RQD, P/E 6.7x, ROIC —, cap $671.4M) and BRUN (Boost Run Inc. (Class A)) posts a D grade (46/100 RQD, P/E N/A, ROIC —, cap $648.6M). Among the 5-stock peer group, DDI leads on earnings multiple (6.7x) while YEXT leads on capital efficiency (34.1% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SOPH?
▼
For SOPHiA GENETICS SA (SOPH), key quantitative strengths include Established market leader in Technology with deep daily trading liquidity. and sector rank #241 in Technology, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±12.5% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
⚔️ Adversarial Opposing Case: Why the SOPH Bull Thesis Could Fail
Even with a 60/100 (C-) score, SOPH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($7.86) or 200D SMA ($5.96) invalidates the momentum regime and cuts Target Base ($7.70) toward Bear Floor ($6.01).
Why SOPH Stock dropped -4.27% Today — RQD Quant Desk Flash
SOPHiA GENETICS SA (SOPH) dropped -4.27% to $7.63, trading at 74% of its 52-week range ($3.83 – $8.98). Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 74% of its 52-week range ($3.83 – $8.98) with RSI-14 at 56.3 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $7.63 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 52% gross margin and $19.0M annual free cash flow.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $14 price target.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (SOPH Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
SOPH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SOPH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SOPH. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SOPH)
1. Head-to-Head Technology Peer Comparison (SOPH vs. DDI, BRUN, YEXT, NRDS)
Industry: EDP Services (163 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, SOPHiA GENETICS SA (SOPH) ranks #241 by composite RQD confidence (60/100, grade C-) and #395 by equity capitalization ($678.5M). Within this direct 5-issuer industry benchmark cohort, DDI leads on earnings valuation at 6.7x trailing P/E, while YEXT leads on capital efficiency and profitability with 34.1% ROIC and 74.5% gross margin. NRDS currently holds the highest overall quantitative score in the immediate peer group at 78/100 (B+) compared with SOPH at 60/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SOPH
ACTIVE
SOPHiA GENETICS SA | C- | 60/100 | — | — | — | -4.27% | $678.5M | Benchmark Subject |
| DDI DoubleDown Interactive Co. Ltd. American Depository Shares | C- | 61/100 | 6.7x | — | — | -0.52% | $671.4M | /ddi-vs-soph → |
| BRUN Boost Run Inc. (Class A) | D | 46/100 | — | — | — | -12.74% | $648.6M | /brun-vs-soph → |
| YEXT Yext Inc. | B- | 71/100 | 19.0x | 74.5% | 34.1% | -1.64% | $723.5M | /yext-vs-soph → |
| NRDS NerdWallet Inc. (Class A) | B+ | 78/100 | 14.9x | 92.4% | 18.6% | -1.50% | $725.5M | /nrds-vs-soph → |
2. SOPH Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTSOPHiA GENETICS SA (SOPH) operates in EDP Services (Technology) with an equity capitalization of $678.5M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. SOPH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SOPH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, SOPHiA GENETICS SA (NASDAQ: SOPH) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $7.63 (-4.27% 1D, market cap $678.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 714 tracked Technology issuers, SOPH ranks #241 in composite RQD confidence.
How does SOPH compare to DDI and BRUN in the Technology sector?
Within the Technology sector (EDP Services), SOPH carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, DDI (DoubleDown Interactive Co. Ltd. American Depository Shares) holds a C- grade (61/100 RQD, P/E 6.7x, ROIC —, cap $671.4M) and BRUN (Boost Run Inc. (Class A)) posts a D grade (46/100 RQD, P/E N/A, ROIC —, cap $648.6M). Among the 5-stock peer group, DDI leads on earnings multiple (6.7x) while YEXT leads on capital efficiency (34.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SOPH?
For SOPHiA GENETICS SA (SOPH), key quantitative strengths include Established market leader in Technology with deep daily trading liquidity. and sector rank #241 in Technology, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SOPH trading relative to its 50-day, 200-day, and 52-week technical levels?
SOPH last traded at $7.63 (-4.27% on volume of 379,226 shares), positioning the stock -2.93% below its 50-day simple moving average ($7.86) and +28.02% above its 200-day simple moving average ($5.96). Across its 52-week range of $3.83 to $8.98, SOPH sits at the 73.8% percentile with a 14-day RSI of 56.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($6.68 to $8.58).
SOPH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SOPH stock moving today?
Why SOPH Stock dropped -4.27% Today — RQD Quant Desk Flash. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.
SOPH — SOPHiA GENETICS SA: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, SOPH scores 60 out of 100, equating to a letter grade of C- and the verdict "Roarable Hold — Cautious Neutral." The fundamental cash engine pillar scores 12 out of 20, with ROIC at 0% and FCF yield at 0%, indicating the source data reflects no current return on invested capital or free-cash-flow generation. The whale/13F flow pillar scores 13 out of 20, reflecting institutional accumulation and options positioning signals; the source does not itemize the underlying 13F holdings. The insider conviction pillar scores 9 out of 20, the lowest of the five, based on SEC Form 4 and Congressional PTR cluster flow, and this is consistent with the insider-sale headlines in the news wire. The macro regime fit pillar scores 13 out of 20, reflecting a beta of 1.0 and sector sensitivity. The forensic balance sheet pillar scores 13 out of 20, supported by an Altman Z-Score of 2.5, a Piotroski F-Score of 6/9, and a Debt/Equity ratio of 0.5.
For a prospective investor, the upside drivers in this rating are the balance-sheet forensics and institutional positioning signals, while the principal drag is the weak insider-conviction reading and the absence of demonstrated cash generation in the source data. The rating frames the stock as a neutral hold rather than a clear accumulation or avoidance case. Valuation tradeoffs cannot be fully assessed because P/E, EV/EBITDA, and EPS are not available in source data, so the price of $7.97 cannot be measured against earnings or cash flow here.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts section:
- Earnings catalyst: SOPHiA GENETICS announced it will report Q3 2026 financial results on November 3, 2026.
- Price movement: A MarketBeat report headlines the stock price as down 5.5%.
- Insider selling: MarketBeat reports headline an insider sale of $28,720.00 in stock, and a Chairman sale of 8,500 shares and a separate Chairman sale of $326,598.36 in stock.
- Analyst rating: A MarketBeat headline reports an average analyst rating of "Hold."
Risk watch items include the cluster of insider and Chairman sales, which aligns with the low insider-conviction pillar. All news items carry a YELLOW light and MARKET WIRE impact label. The Butterfly Supply-Chain Graph lists no supply-chain relationships and no proprietary signals.
Analyst View & Smart Money Ownership
Analyst data is not available in source data, so consensus price targets cannot be reported. Holder data is also not available in source data, so 13F, Form 4 insider holdings, and Congressional trades cannot be itemized beyond the news-wire headlines and the RQD pillar scores described above.
Open Questions
- What are SOPH's reported revenue, operating income, net income, and free cash flow across recent periods, given that the financials section is empty?
- What are the trailing and forward earnings and valuation multiples, which are unavailable in the source data?
- What products and customers generate SOPH's revenue, and what is the business model?
- What is the scale and direction of the institutional 13F and options positioning behind the whale-flow pillar score?
- Does the Q3 2026 earnings release on November 3, 2026 alter the fundamental cash-engine reading of 0% ROIC and 0% FCF yield?
SOPH Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for SOPHiA GENETICS SA (SOPH) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering SOPHiA GENETICS SA (SOPH) market action, institutional positioning, and fundamental catalysts.
SOPH Bull vs. Bear Conversation Board — What's Your Call at $7.63?
🔥 Official Bull vs. Bear Debate: Is SOPH (C- • RQD 60/100) a Buy at $7.97?
Welcome to the SOPH (SOPHiA GENETICS SA) Roar Pit. Current RQD Composite is 60/100 (Roarable Hold — Cautious Neutral) in EDP Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on SOPH — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on SOPH, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless SOPHiA GENETICS SA expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
SOPH cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on SOPH, the market is fixating on short-term headline noise in EDP Services and ignoring the balance sheet and cash flow trajectory. At $7.97 (52-wk range $3.83 - $8.98), any beat on forward guidance forces shorts and underweight funds to chase.